MetLife Investment Management’s Arteris AIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1M Buy
20,604
+4,022
+24% +$129K ﹤0.01% 1521
2026
Q1
$273K Sell
16,582
-369
-2% -$5.85K ﹤0.01% 2063
2025
Q4
$263K Hold
16,951
– – ﹤0.01% 2143
2025
Q3
$171K Hold
16,951
– – ﹤0.01% 2406
2025
Q2
$162K Hold
16,951
– – ﹤0.01% 2295
2025
Q1
$117K Hold
16,951
– – ﹤0.01% 2454
2024
Q4
$173K Hold
16,951
– – ﹤0.01% 2369
2024
Q3
$131K Buy
16,951
+9,551
+129% +$73.7K ﹤0.01% 2513
2024
Q2
$55.6K Buy
+7,400
New +$56.3K ﹤0.01% 2742

Other funds holding AIP

MetLife Investment Management's AIP Position: Q2 2026 in Review

MetLife Investment Management increased its Arteris (AIP) stake by 24% in Q2 2026, buying an estimated $129K and bringing the position to 20,604 shares worth $1M. The position accounts for ﹤0.01% of the portfolio, ranked #1521.

MetLife Investment Management first reported a position in AIP in Q2 2024 and has held it in 9 quarters since. 211 funds tracked by Wall St. Rank hold AIP as of Q2 2026.

  • MetLife Investment Management held 20,604 shares of Arteris worth $1M as of Q2 2026.
  • MetLife Investment Management bought 4,022 Arteris shares in Q2 2026, an estimated $129K.
  • Arteris made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1521 holding.
  • MetLife Investment Management first reported a position in Arteris in Q2 2024 and has held it in 9 quarters since.
  • 211 funds tracked by Wall St. Rank held Arteris as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.